Ukr.Biochem.J. 2021; Volume 93, Issue 6, Nov-Dec, pp. 87-92
doi: https://doi.org/10.15407/ubj93.06.087
TLR4 gene expression in patients with chronic suppurative otitis media
J. T. Venkataravanappa1, K. C. Prasad2, S. Balakrishna1*
1Department of Cell Biology and Molecular Genetics, Sri Devraj Urs Academy of Higher Education and Research, Karnataka, India;
2Department of Otorhinolaryngology, Sri Devaraj Urs Medical College, Sri Devraj Urs Academy of Higher Education and Research, Kolar-563103, Karnataka, India;
*e-mail: sharath@sduu.ac.in
Received: 23 July 2021; Accepted: 12 November 2021
Chronic suppurative otitis media (CSOM) is an infectious disease of the middle ear that involves inflammation and accumulation of fluid behind the eardrum. The pathogenesis of CSOM involves reduced bacterial clearance due to impairment of Toll-Like Receptor (TLR) 4 pathway. TLR4 receptor serves as the molecular sensor for bacterial endotoxin (lipopolysaccharide) and activates inflammatory cell signaling for clearing the bacteria. Previous studies have shown that the expression of TLR4 gene is reduced in middle ear epithelia of CSOM patients. Whether the expression of TLR4 gene is reduced in leukocytes is not known. In our present study we aim to compare the expression of the TLR4 gene in the blood samples of CSOM patients and healthy controls. A case-control study was carried out by involving 16 participants in each group. The levels of the TLR4 gene expression were measured by using the qRT-PCR method. The median (interquartile range) ΔCt values of the TLR4 gene expression was 4.85 (2.61- 8.55) in the patient group and 2.29 (-1.63-4.85) in healthy controls. Expression of the TLR4 gene in the leukocytes of CSOM patient group was reduced by ~5.9 fold compared to the control group and the difference was found to be significant (P = 0.01).
Keywords: chronic suppurative otitis media, gene expression, toll-like receptor 4 (TLR4)
References:
- Mittal R, Lisi CV, Gerring R, Mittal J, Mathee K, Narasimhan G, Azad RK, Yao Q, Grati M, Yan D, Eshraghi AA, Angeli SI, Telischi FF, Liu XZ. Current concepts in the pathogenesis and treatment of chronic suppurative otitis media. J Med Microbiol. 2015;64(10):1103-1116. PubMed, PubMedCentral, CrossRef
- Bhutta MF, Thornton RB, Kirkham LAS, Kerschner JE, Cheeseman MT. Understanding the aetiology and resolution of chronic otitis media from animal and human studies. Dis Model Mech. 2017;10(11):1289-1300. PubMed, PubMedCentral, CrossRef
- Hutz MJ, Moore DM, Hotaling AJ. Neurological Complications of Acute and Chronic Otitis Media. Curr Neurol Neurosci Rep. 2018;18(3):11. PubMed, CrossRef
- Muftah S, Mackenzie I, Faragher B, Brabin B. Prevalence of Chronic Suppurative Otitis Media (CSOM) and Associated Hearing Impairment Among School-aged Children in Yemen. Oman Med J. 2015;30(5):358-365. PubMed, PubMedCentral, CrossRef
- Balan S, Viswanatha B. Microbiology of Chronic Suppurative Otitis Media: A Prospective Study in a Tertiary Care Hospital. J Otolaryngol ENT Res. 2017;9(1):00277. CrossRef
- Nie L, Cai SY, Shao JZ, Chen J. Toll-Like Receptors, Associated Biological Roles, and Signaling Networks in Non-Mammals. Front Immunol. 2018;9:1523. PubMed, PubMedCentral, CrossRef
- Molteni M, Gemma S, Rossetti C. The Role of Toll-Like Receptor 4 in Infectious and Noninfectious Inflammation. Mediators Inflamm. 2016;2016:6978936. PubMed, PubMedCentral, CrossRef
- Zmonarski SC, Banasik M, Madziarska K, Mazanowska O, Krajewska M. The role of toll-like receptors in multifactorial mechanisms of early and late renal allotransplant injury, with a focus on the TLR4 receptor and mononuclear cells. Adv Clin Exp Med. 2019;28(7):981-987. PubMed, CrossRef
- Zhang J, Xu M, Zheng Q, Zhang Y, Ma W, Zhang Z. Blocking macrophage migration inhibitory factor activity alleviates mouse acute otitis media in vivo. Immunol Lett. 2014;162(1 Pt A):101-108. PubMed, PubMedCentral, CrossRef
- Granath A, Cardell LO, Uddman R, Harder H. Altered Toll- and Nod-like receptor expression in human middle ear mucosa from patients with chronic middle ear disease. J Infect. 2011;63(2):174-176. PubMed, CrossRef
- Harmes KM, Blackwood RA, Burrows HL, Cooke JM, Harrison RV, Passamani PP. Otitis media: diagnosis and treatment. Am Fam Physician. 2013;88(7):435-440. PubMed
- Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques. 1993;15(3):532-534, 536-537. PubMed
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-408. PubMed, CrossRef
- Si Y, Zhang ZG, Chen SJ, Zheng YQ, Chen YB, Liu Y, Jiang H, Feng LQ, Huang X. Attenuated TLRs in middle ear mucosa contributes to susceptibility of chronic suppurative otitis media. Hum Immunol. 2014;75(8):771-776. PubMed, CrossRef
- Granath A, Uddman R, Cardell LO. Increased TLR7 expression in the adenoids among children with otitis media with effusion. Acta Otolaryngol. 2010;130(1):57-61. PubMed, CrossRef
- Tuoheti A, Gu X, Cheng X, Zhang H. Silencing Nrf2 attenuates chronic suppurative otitis media by inhibiting pro-inflammatory cytokine secretion through up-regulating TLR4. Innate Immun. 2021 Jan;27(1):70-80. PubMed, PubMedCentral, CrossRef
- MacArthur CJ, Hefeneider SH, Kempton JB, Trune DR. C3H/HeJ mouse model for spontaneous chronic otitis media. Laryngoscope. 2006;116(7):1071-1079. PubMed, CrossRef
- Leichtle A, Hernandez M, Pak K, Yamasaki K, Cheng CF, Webster NJ, Ryan AF, Wasserman SI. TLR4-mediated induction of TLR2 signaling is critical in the pathogenesis and resolution of otitis media. Innate Immun. 2009;15(4):205-215. PubMed, PubMedCentral, CrossRef
- Emonts M, Veenhoven RH, Wiertsema SP, Houwing-Duistermaat JJ, Walraven V, de Groot R, Hermans PWM, Sanders EAM. Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media. Pediatrics. 2007;120(4):814-823. PubMed, CrossRef
- Hafrén L, Einarsdottir E, Kentala E, Hammarén-Malmi S, Bhutta MF, MacArthur CJ, Wilmot B, Casselbrant M, Conley YP, Weeks DE, Mandel EM, Vaarala O, Kallio A, Melin M, Nieminen JK, Leinonen E, Kere J, Mattila PS. Predisposition to Childhood Otitis Media and Genetic Polymorphisms within the Toll-Like Receptor 4 (TLR4) Locus. PLoS One. 2015;10(7):e0132551. PubMed, PubMedCentral, CrossRef
- Alpay HC, Etem EO, Kaygusuz I, Yüce H, Karlidag T, Keles E, Orhan I, Yalcin S. Evaluation of the polymorphism in the Toll-like receptor 4 (TLR4) genes of tympanosclerosis patients. Auris Nasus Larynx. 2010;37(1):29-32. PubMed, CrossRef
This work is licensed under a Creative Commons Attribution 4.0 International License.